nhs healthcare contracts

Market Engagement Event Talking Therapies and Psychological Therapies for Severe Mental Health Problems (TT & PTSMHP) in Essex This Prior Information Notice (PIN) is intended to notify the market of the Market Engagement event only. This PIN is NOT a call for competition. The Contracting Authority on behalf of Mid and South Essex, North East Essex and West Essex, Integrated Care Boards, to be succeeded by the proposed new Essex ICB from 1st April 2026 (hereafter referred to as "the Authority") invites suitably qualified providers to attend a virtual Market Engagement event which will inform the market of the Authority's intention to commission Talking Therapies (TT) and Psychological Therapies for Severe Mental Health Problems (PT SMHP) for Essex. The Market Engagement event will take place virtually via MS Teams on Monday 20th April 2026 from 10:0am - 11:0am. The event will offer an opportunity to engage with stakeholders and for prospective service providers to learn more about the service. The procurement process and timetable will also be shared. To express an interest, please follow the link and complete the registration form directly in the MS Teams webinar link: https://events.teams.microsoft.com/event/a9e0d005-b811-4527-84e7-f4fa8b10bddb@b5fa915c-fcb7-43a5-a5ad-631d989f6e1d The closing date for registering attendance is 12:0noon on Friday 17th April 2026. The event will be recorded, and all materials will be shared with interested providers. The indicative high-level timeline below is being issued by the Authority for information only and may be subject to change: Tender Period: 1st May 26 – 05th June 26 Evaluation & Moderation June – July 26 Governance: August 26 Notice of Outcome: 14th August 26 Standstill Period: midnight 26th August 26 Award: 27th August 26 Mobilisation: September 26 – March 27 Service go-live: 1st April 2027 The Authority has published this PIN to support market engagement for this TT PTSMHP services only. Any future procurement opportunities pertaining to these services, if undertaken, will be advertised with a separate call for competition via a relevant notice published in the Central Digital Platform (CDP) and all appropriate platforms, once final. Please note: Commercially sensitive information and Freedom of Information Respondents’ views or submissions will not be individually identified or revealed to third parties. All information provided in this exercise will be treated in confidence and will NOT be considered in any future tender evaluation exercise. Information gathered may be used in the development of the procurement approach and final Specification for the Service prior to the Invitation to Tender being issued in May. Any information provided in response to this market engagement exercise marked as commercially sensitive will be treated as such. Respondents are asked to identify any of the information supplied in the course of this exercise which should not be disclosed because of its sensitivity. In doing so respondents must specify the reasons for its sensitivity and specify the period for which the information will remain sensitive for the Authority’s records. Respondents should seek their own legal advice on the application of freedom of information legislation. The Authority will consider statements of confidentiality and commercial sensitivity that are provided by respondents and will endeavour to consult with respondents about sensitive information before deciding on any FOI requests received, but the Respondent must make its own assessment and decision on these issues. For avoidance of doubt, the final decision on any FOI request rests with the relevant public body, subject to applicable law.

NHS Mid and South Essex Integrated Care Board (the Authority) intends to award three contracts to deliver Level 1 Sedation Services for children and adults in Mid and South Essex, following a Most Suitable Provider (MSP) process under the Health Care Services (Provider Selection Regime) Regulations 2023. Level 1 conscious sedation services provide basic, safe sedation, mainly inhalation sedation and single drug intravenous sedation, to help patients undergo routine dental treatment. These services follow nationally recognised IACSD Standards, which set requirements for trained staff, appropriate clinical environments, monitoring, and safe recovery. The Authority seeks to increase Level 1 dental sedation capacity in North Mid and South Essex, specifically from Chelmsford northwards, with services located along the A12/A120 corridor to ensure good patient access. Providers will only be deemed suitable therefore if they operate an existing dental practice within this defined catchment. In applying the Process, the Authority has assessed the five Key Criteria and updated its provider landscape knowledge through a key criteria assessment and data gathering process, to confirm provider capability and local connections. Based on its assessment, the Authority believes it can identify the MSP without a competitive process.